← Leaderboards
Bernadette C Holdener
State University New York Stony Brook
$6,155,808
Attributed
$10,172,532
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,172,532 · 5
By mechanism
R01$10,172,532 · 5
Top collaborators
- Robert S. Haltiwanger14 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMutationTissuesIn VitroDefectIn VivoCellsMediatingAffectEndoplasmic ReticulumLinkMutantConsensus SequenceMolecularGlucoseKnockout MiceModificationPhenotypeProtein FoldingBaseDatabasesBiologicalGlycosylationPathway Interactions
Grant awards (22)
Role of POGLUT2 and POGLUT3 in regulating microfibril structure and function$687,416
R01 · FY2025 · HL
Role of POGLUT2 and POGLUT3 in regulating microfibril structure and function$673,668
R01 · FY2024 · HL
Role of POGLUT2 and POGLUT3 in regulating microfibril structure and function$687,416
R01 · FY2023 · HL
Role of POGLUT2 and POGLUT3 in regulating microfibril structure and function$698,891
R01 · FY2022 · HL
Role of Beta3-Glucosyltransferase in a non-canonical quality control pathway$561,875
R01 · FY2022 · HD
Role of Beta3-Glucosyltransferase in a non-canonical quality control pathway$561,875
R01 · FY2021 · HD
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development$475,867
R01 · FY2021 · HD
Role of Beta3-Glucosyltransferase in a non-canonical quality control pathway$573,342
R01 · FY2020 · HD
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development$485,579
R01 · FY2020 · HD
Role of Beta3-Glucosyltransferase in a non-canonical quality control pathway$574,822
R01 · FY2019 · HD
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development$485,579
R01 · FY2019 · HD
Role of Beta3-Glucosyltransferase in a non-canonical quality control pathway$584,312
R01 · FY2018 · HD
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development$485,514
R01 · FY2018 · HD
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and development$497,292
R01 · FY2017 · HD
The biochemical mechanism of Wnt signaling$222,257
R01 · FY2007 · CA · contact PI
Biochemical and genetic analysis of mesd function$359,376
R01 · FY2006 · GM · contact PI
Biochemical and genetic analysis of mesd function$28,617
R01 · FY2006 · GM · contact PI
Biochemical and genetic analysis of mesd function$338,625
R01 · FY2005 · GM
Biochemical and genetic analysis of mesd function$338,625
R01 · FY2004 · GM
Biochemical and genetic analysis of mesd function$315,900
R01 · FY2003 · GM
GENETIC ANALYSIS OF MESODERM INDUCTION IN MICE$271,801
R01 · FY2001 · GM
GENETIC ANALYSIS OF MESODERM INDUCTION IN MICE$263,883
R01 · FY2000 · GM